#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2319020	A	Oral bioavailability in rat	Rattus norvegicus	1		organism-based format	Scientific Literature
2.	ALA2319021	A	Clearance in rat	Rattus norvegicus	1		organism-based format	Scientific Literature
3.	ALA2319022	P	Solubility of the compound at pH 7.4		1		small-molecule physicochemical format	Scientific Literature
4.	ALA2319023	A	Apparent permeability of the compound in human Caco2 cells	Homo sapiens	1		cell-based format	Scientific Literature
5.	ALA2319024	A	Intrinsic clearance in human liver microsomes	Homo sapiens	1		microsome format	Scientific Literature
6.	ALA2319025	T	Toxicity in New Zealand white rabbit assessed as CNS effect at plasma concentration of 3 to 4 times 20% change in atrium effective refractory period	Oryctolagus cuniculus	2		organism-based format	Scientific Literature
7.	ALA2319027	F	Increase of effective refractory period in New Zealand white rabbit assessed as maximum change in QT interval at 0.1 and 1 umol/kg/min for 15 mins infusions	Oryctolagus cuniculus	2		organism-based format	Scientific Literature
8.	ALA2319028	P	Lipophilicity, log D of compound at pH 7.4		2		small-molecule physicochemical format	Scientific Literature
9.	ALA2319029	A	Unbound steady state plasma concentration in New Zealand white rabbit assessed as concentration required to 20% change in atrium effective refractory period at 0.1 and 1 umol/kg/min for 15 mins infusions	Oryctolagus cuniculus	2		cell-free format	Scientific Literature
10.	ALA2319030	B	Inhibition of IK channel (unknown origin)	Homo sapiens	23		single protein format	Scientific Literature
11.	ALA2319031	B	Inhibition of human ERG	Homo sapiens	15		single protein format	Scientific Literature
12.	ALA2319032	B	Inhibition of human Kv1.5 channel expressed in CHO cells by high throughput planar patch clamp assay	Homo sapiens	24		cell-based format	Scientific Literature
13.	ALA3301363	P	ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5		4,197		small-molecule physicochemical format	AstraZeneca Deposited Data
14.	ALA3301365	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Homo sapiens	1,614		cell-free format	AstraZeneca Deposited Data
15.	ALA3301366	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Rattus norvegicus	717		cell-free format	AstraZeneca Deposited Data
16.	ALA3301367	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole dog plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Canis lupus familiaris	244		cell-free format	AstraZeneca Deposited Data
17.	ALA3301368	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole mouse plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Mus musculus	162		cell-free format	AstraZeneca Deposited Data
18.	ALA3301369	A	ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole guinea pig plasma at 37C for >5hrs. Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.	Cavia porcellus	91		cell-free format	AstraZeneca Deposited Data